Showing 1,285 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Poor adherence, high viral loads help explain rilpivirine treatment failures

Editor's pick
AIDSMeds.com
17 September 2010
Drug interactions & pharmacokinetics

Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

Editor's pick
Doctor's Guide
16 September 2010
New & experimental HIV treatments

ICAAC: Study Closes Vicriviroc Story

Editor's pick
MedPage Today
16 September 2010
New & experimental HIV treatments

GSK new NNRTI selects no resistance mutations in 7 days of monotherapy

Editor's pick
NATAP
16 September 2010
New & experimental HIV treatments

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

Editor's pick
News-Medical-Net
16 September 2010
New & experimental HIV treatments

Elvitegravir "Quad" single-tablet regimen shows continued HIV suppression at 48 weeks

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

New NRTI festinavir exhibits good anti-HIV activity and safety in phase 1b/2a study

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Gilead Sciences submits European marketing application for once-daily single-tablet regimen of Truvada(R) and TMC278 for the treatment of HIV infection

Editor's pick
Market Watch
3 September 2010
New & experimental HIV treatments

AIDS cure quest to kill `sleeping' viruses enlists Merck cancer medicine

Editor's pick
Bloomberg
2 September 2010
New & experimental HIV treatments

Cocktails are next for cancer-drug makers

Editor's pick
Bloomberg Business Week
27 August 2010
New & experimental HIV treatments

Researchers Identify Two FDA Approved Drugs That May Fight HIV

Editor's pick
Science Daily
24 August 2010
New & experimental HIV treatments

Maraviroc potentially of benefit for many patients with late HIV diagnosis

News
16 August 2010
New & experimental HIV treatments

Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir

Editor's pick
PR Newswire
28 July 2010
New & experimental HIV treatments

Therapeutic HIV vaccines show promise

Editor's pick
Scientific American
28 July 2010
New & experimental HIV treatments

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

News
26 July 2010
New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
New & experimental HIV treatments

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

News
20 July 2010
New & experimental HIV treatments

Merck stops development of CCR5 inhibitor vicriviroc

News
15 July 2010
New & experimental HIV treatments

Avexa licenses integrase inhibitor to Chinese partner

Editor's pick
Avexa
14 July 2010
The search for a cure

HIV cure efforts severely underfunded, US activists report

News
13 July 2010
HIV treatment for children & young people

Atazanavir for children approved in European Union

News
8 July 2010
New & experimental HIV treatments

LSUHSC awarded $4 million to understand effect of THC on HIV

Editor's pick
Moreover.com HIV/AIDS feed
7 July 2010